ReviewCytotherapy2025

Advancing gene-editing platforms to improve the viability of rare-disease therapeutics: key insights from a 2024 Scientific Exchange hosted by ARM, ISCT, and Danaher.

Fyodor Urnov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.